The JAK2 46/1 (GGCC) MPN-predisposing haplotype: A risky haplotype, after all

被引：3
|
作者：
Vannucchi, Alessandro M.
Guglielmelli, Paola
机构：
[1] Univ Firenze, Dipartimento Med Sperimentale & Clin, Azienda Osped Univ Careggi, CRIMM, Florence, Italy
[2] DENOTHE Excellence Ctr, Florence, Italy
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2019年 / 94卷 / 03期
关键词：
MYELOPROLIFERATIVE NEOPLASMS; CONFERS SUSCEPTIBILITY; MYELOFIBROSIS; RUXOLITINIB; FREQUENCY; SURVIVAL; V617F; TERT; SNP;
D O I：
10.1002/ajh.25367
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：283 / 285
页数：3
相关论文
共 50 条
  • [21] The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms
    Olcaydu, Damla
    Rumi, Elisa
    Harutyunyan, Ashot
    Passamonti, Francesco
    Pietra, Daniela
    Pascutto, Cristiana
    Berg, Tiina
    Jaeger, Roland
    Hammond, Emma
    Cazzola, Mario
    Kralovics, Robert
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (03): : 367 - 374
  • [22] Erythrocytosis with JAK2 GGCC_46/1 haplotype and without JAK2 V617F mutation is associated with CALR rs1049481_G allele
    Luisa Anelli
    Paola Orsini
    Antonella Zagaria
    Angela Minervini
    Nicoletta Coccaro
    Elisa Parciante
    Crescenzio Francesco Minervini
    Cosimo Cumbo
    Giuseppina Tota
    Luciana Impera
    Maria Rosa Conserva
    Immacolata Redavid
    Francesco Tarantini
    Alessandra Ricco
    Immacolata Attolico
    Giorgina Specchia
    Francesco Albano
    Leukemia, 2021, 35 : 619 - 622
  • [23] Erythrocytosis with JAK2 GGCC_46/1 haplotype and without JAK2 V617F mutation is associated with CALR rs1049481_G allele
    Anelli, Luisa
    Orsini, Paola
    Zagaria, Antonella
    Minervini, Angela
    Coccaro, Nicoletta
    Parciante, Elisa
    Minervini, Crescenzio Francesco
    Cumbo, Cosimo
    Tota, Giuseppina
    Impera, Luciana
    Conserva, Maria Rosa
    Redavid, Immacolata
    Tarantini, Francesco
    Ricco, Alessandra
    Attolico, Immacolata
    Specchia, Giorgina
    Albano, Francesco
    LEUKEMIA, 2021, 35 (02) : 619 - 622
  • [24] The Characteristics of Patients With Unprovoked Venous Thrombotic Events With JAK2 GGCC (46/1) Haplotype Treated in Tertiary Care Center in Saudi Arabia
    Alanazi, Shatha
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S340 - S341
  • [25] The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms
    Jones, Amy V.
    Campbell, Peter J.
    Beer, Philip A.
    Schnittger, Susanne
    Vannucchi, Alessandro M.
    Zoi, Katerina
    Percy, Melanie J.
    McMullin, Mary Frances
    Scott, Linda M.
    Tapper, William
    Silver, Richard T.
    Oscier, David
    Harrison, Claire N.
    Grallert, Harald
    Kisialiou, Aliaksei
    Strike, Paul
    Chase, Andrew J.
    Green, Anthony R.
    Cross, Nicholas C. P.
    BLOOD, 2010, 115 (22) : 4517 - 4523
  • [26] The JAK2 46/1 haplotype is a risk factor for myeloproliferative neoplasms in Chinese patients
    Xinju Zhang
    Tingting Hu
    Zhiyuan Wu
    Zhihua Kang
    Weiwei Liu
    Ming Guan
    International Journal of Hematology, 2012, 96 : 611 - 616
  • [27] The JAK2 46/1 haplotype is a risk factor for myeloproliferative neoplasms in Chinese patients
    Zhang, Xinju
    Hu, Tingting
    Wu, Zhiyuan
    Kang, Zhihua
    Liu, Weiwei
    Guan, Ming
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 96 (05) : 611 - 616
  • [28] The JAK2 46/1 Haplotype Predisposes to Myeloproliferative Neoplasms Characterized by Diverse Mutations
    Cross, Nicholas C. P.
    Campbell, Peter
    Beer, Philip A.
    Schnittger, Susanne
    Vannucchi, Alessandro M.
    Zoi, Katerina
    Percy, Melanie
    McMullin, Mary Frances
    Scott, Linda
    Silver, Richard T.
    Oscier, David
    Harrison, Claire
    Green, Anthony R.
    Chase, Andrew
    BLOOD, 2009, 114 (22) : 180 - 180
  • [29] JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia
    H Andrikovics
    S Nahajevszky
    M Koszarska
    N Meggyesi
    A Bors
    G Halm
    S Lueff
    N Lovas
    Z Matrai
    J Csomor
    R Rasonyi
    M Egyed
    J Varkonyi
    G Mikala
    A Sipos
    A Kozma
    E Adam
    S Fekete
    T Masszi
    A Tordai
    Leukemia, 2010, 24 : 1809 - 1813
  • [30] JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia
    Andrikovics, H.
    Nahajevszky, S.
    Koszarska, M.
    Meggyesi, N.
    Bors, A.
    Halm, G.
    Lueff, S.
    Lovas, N.
    Matrai, Z.
    Csomor, J.
    Rasonyi, R.
    Egyed, M.
    Varkonyi, J.
    Mikala, G.
    Sipos, A.
    Kozma, A.
    Adam, E.
    Fekete, S.
    Masszi, T.
    Tordai, A.
    LEUKEMIA, 2010, 24 (10) : 1809 - 1813
12345